This stock is re-emerging as a modest-growth story at a cheap valuation, with a very strong balance sheet.
Get this delivered to your inbox, and more info about our products and services.
Shares have hit their lowest level since June, despite reporting a decent quarter last week.
We're taking half of the cash raised from the sale to add to one of the portfolio's recent spinoffs.
We're also downgrading the stock in conjunction with the sale.
Investors may need to keep an eye out for companies that don't having the earnings to justify their high valuations.
The stock is one of seven out-of-favor names Jim Cramer highlighted at our recent Monthly Meeting.
We're nibbling on shares and averaging down our cost basis.
